Pharmaceutical Patent Life Cycles

Venue: London

Location: London, United Kingdom

Event Date/Time: Apr 22, 2004
Report as Spam


EuroLegal's third and completely updated Advanced Legal Guide to Maximising Pharmaceutical Patent Life Cycles will bring you thoughtful and targeted commentary and in-depth analysis from an outstanding faculty of leading in-house counsel and lawyers from key companies including GlaxoSmithKline, Sanofi-Synthelabo, Pfizer Limited, Amersham plc, The European Patent Office, Rib-X Pharmaceuticals, Lovells and many more.

Highlights of this conference include:
· How to ensure total protection for our pharmaceutical products
· The EPO's current position on extending patent life
· SPCs throughout Europe, Japan and the US
· Hatch Waxman Reforms, Medicare Reform and the FDA’s final rule
· Current FTC enforcement activity
· Data protection, marketing exclusivity and market entry obstacles — in Europe and the US
· Which R&D activities fall within the experimental use exemption and the Safe Harbor provisions?
· Litigation strategies in Europe and the US which will maximise your patent life cycles